Muscarinic M1 receptor partial agonist

This page covers all Muscarinic M1 receptor partial agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting M1 muscarinic acetylcholine receptor.

Targets

M1 muscarinic acetylcholine receptor

Phase 3 pipeline (1)

• ALKS 2680 Dose 1 · Alkermes, Inc. · Psychiatry/Neurology
  ALKS 2680 is a muscarinic M1 receptor partial agonist designed to enhance cognitive function and treat psychiatric symptoms.